According to Maximize Market Research experts, “Global Organ preservation Market 2022 Insights, Size, Share, Growth, Opportunities, Emerging Trends, Forecast to 2029.” The study is an anthology of in-depth research studies on many aspects of the global Organ preservation industry. It is an admirable effort to offer a true, transparent picture of the current and future conditions of the global Organ preservation market, based on credible facts and exceptionally accurate data.
Global Organ Preservation Market was valued at US$ 0.23 Bn. in 2021. The global Organ preservation Market is expected to grow at a CAGR of 6.6 % through the forecast period.
Global Organ preservation Market Overview:
Organ preservation is the supply line for organ transplantation. Currently, the liver, pancreas, and kidney can be successfully preserved for up to two days by being flushed with the University of Wisconsin (UW) organ preservation solution and kept at hypothermia (0-5 degrees C). Because the UW solution contains various cell-impermeant ingredients (including lactobionic acid, raffinose, and hydroxyethyl starch), which prevent the cells from swelling during cold ischemic storage, it works efficiently. In addition, the UW solution contains glutathione and adenosine, which can help the organs' ability to fight off free radicals during reperfusion (glutathione) or help the body's ability to make high-energy phosphates (adenosine) following reperfusion.
Maximize Market Research provides an overview of the Organ preservation market, as well as a dynamic analysis, a description of its features, country-level industry statistics, important market trends, and market projections in this report. A Maximize Market research study gives businesses the most up-to-date data on new items they're introducing. During the forecast period, the study identifies the geographical regions with the greatest market share projections.
Request To Download Free Sample of This Strategic Report: https://www.maximizemarketresearch.com/request-sample/39247
Market Dynamics:
Drivers: An increase in the number of elderly people and consequent incidences of multiple organ failure
Multiple organ failure, which is predominantly caused by sepsis, is one of the most common causes of death in ICUs. Estimates show that up to 20% of sepsis patients experience acute respiratory failure and 26–50% experience acute renal failure (Source: Society of Critical Care Medicine). Because renal plasma flow and glomerular filtration rate drop with age, acute renal failure is more prevalent in the elderly. People with diabetes are more prone to developing both of these illnesses as well as multiple organ failure. Patients in their advanced years are more likely to suffer from conditions like liver cirrhosis and TB, which may call for organ transplantation. According to the Organ Procurement and Transplantation Network, there is a direct correlation between the number of old people receiving organ transplants and the volume of organ transplant surgeries carried out. For example, in the US, the number of organ transplants for people over 65 increased from 8,691 in 2019 to 8,895 in 2021. In 2020, there were 728 million people in the globe who were 65 or older, according to the UN World Population Ageing Report; this figure is expected to rise to 1.5 billion by 2050, indicating a potential increase in demand. This population's growth will have a significant impact on the market's expansion because it is more likely to suffer from illnesses that result in organ failure.
Market Segmentations:
Based on Type, In 2021, the kidney market category had the largest market share. Renal failure cases and kidney transplant procedures are the key factors influencing market growth. According to a 2019 estimate from the NHS, around 37.00 million Americans have chronic kidney disease, and nearly 726,000 get end-stage renal disease each year. Additionally, it is anticipated that several awareness programmes highlighting the benefits of kidney transplantation will spur market expansion. For instance, the NHS launched the "Advancing American Renal Health" Initiative to enhance the quality of life for Americans who suffer from kidney disease. During the projection period, the heart segment is anticipated to develop at the greatest CAGR of xx percent. The category is anticipated to expand more quickly throughout the forecast period as a result of the rise in heart transplant procedures. According to a survey published by the Health Resources & Services Administration, 3,273 heart transplant procedures were performed in 2017 as opposed to 3,408 in 20121. This tendency is anticipated to propel the segment's growth over the future years.
Company Profiles:
• Paragonix Technologies
• XVIVO Perfusion AB
• Dr. Franz Köhler Chemie GmbH (Germany),
• Essential Pharmaceuticals,
• LLC (US)
• Organix Limited (UK)
• 21st Century Medicine (USMedicine, Inc.
• Shanghai Genext Medical
• Bridge to Life Limited
• Preservation Solutions
• Carnamedica (Poland)
• Transplant Biomedicals
• Institut Georges Lopez
• Global Transplant Solutions
• Organ Preservation Vascular Perfusion
To gain a better grasp of the current situation of the Organ preservation market and the majority of the country's policies, Maximize Market Research forecasts future growth in the target industry. The market size estimations and segment development trends, as well as qualitative and quantitative insights into the Organ preservation market, are included in this study.
Regional Analysis:
North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa are all covered in the MMR report. This research looks at important market segments and subsectors, as well as significant market sectors. MMR conducts a study of creative countries in neighbourhood development based on market size, share, and quantity. Statistical data includes quantity, area, revenue, market chain system, and trends, as well as demographic data.
COVID-19 Impact Analysis on Organ preservation Market:
The COVID-19 rule had a considerable impact on workers', businesses', and the general public's expectations in 2020 and 2021. COVID-19 needs immediate and innovative industry help to avoid disturbance to our society and level of living. COVID-19 has caused problems for a lot of expatriates. As a result of the restrictions, thousands of migrant workers have lost their employment, and they are experiencing food shortages and worry about their futures.
This Maximize Market Research Report is intended to assist you in learning more about the current economy, COVID-19, and its commercial implications. Since COVID-19, Maximize market research has grown throughout all industries, sectors, and specialties. Similar data is available in the Maximize Market Research Report (MMR), which may be used to investigate how COVID-19 affects industry losses and growth.
Key Questions Answered in the Organ preservation Market Report are:
- Which product segment grabbed the largest share in the Organ preservation market?
- How is the competitive scenario of the Organ preservation market?
- Which are the key factors aiding the Organ preservation market growth?
- Which region holds the maximum share in the Organ preservation market?
- What will be the CAGR of the Organ preservation market during the forecast period?
- Which application segment emerged as the leading segment in the Organ preservation market?
- Which are the prominent players in the Organ preservation market?
- What key trends are likely to emerge in the Organ preservation market in the forecast period?
- What is the expected Organ preservation market size by 2029?
- Which company held the largest share in the Organ preservation market?
If You Have Any Questions About This Report? Please Contact Us On the link mentioned below: https://www.maximizemarketresearch.com/market-report/global-organ-preservation-market/39247/
Contact Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email: sales@maximizemarketresearch.com
Phone No.: +91 20 6630 3320
Website: www.maximizemarketresearch.com
About Us:
Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.